Form TA-1/A Fidelity Business Servic
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20250904/AKZYQ22CG222E2Z2222H22Z9854EZ22S6272
Filed on: August 21, 2025
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Otsuka Receives FDA Approval for First-in-Class SIMTRIYO® (centanafadine) for the Treatment of Attention-Deficit Hyperactivity Disorder (ADHD) in Adults and Pediatric Patients Aged 6 Years and Older
- DesignNBuy Adds Sticker Product Support and Step & Repeat Pattern Tool to DesignO Design Platform
- ARCPOINT PROVIDES LEADERSHIP UPDATE
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
